1. UnitedHealth's stock has fallen 56% in a year, yet insiders and institutional investors are increasing their stakes; 2. Despite disappointing Q2 earnings, new strategic guidance and cost-cutting measures may signal a potential recovery; 3. The author's bearish valuation still projects nearly 30% upside potential for UNH.